ARCHIVES

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

In Brief: O’Conor Now Top Prospect If Rauscher Leaves; Flood Gives NCI Increase Of Only $11 Million

May 14, 1976

Nominations Sought For Women’s Health Achievement AwardsFor Medical Devices

February 7, 1997

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

June 14, 2013

Schmitt To Chair Senate Health Appropriations Subcommittee

January 2, 1981